These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28359747)

  • 61. Roles of preoperative lymphoscintigraphy for sentinel lymph node biopsy in breast cancer patients.
    Sun X; Liu JJ; Wang YS; Wang L; Yang GR; Zhou ZB; Li YQ; Liu YB; Li TY
    Jpn J Clin Oncol; 2010 Aug; 40(8):722-5. PubMed ID: 20430775
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.
    Newman EA; Cimmino VM; Sabel MS; Diehl KM; Frey KA; Chang AE; Newman LA
    Ann Surg Oncol; 2006 Jan; 13(1):52-7. PubMed ID: 16372155
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer.
    Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W
    J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preoperative dynamic lymphoscintigraphy predicts sentinel lymph node metastasis in patients with early breast cancer.
    Nakashima K; Kurebayashi J; Sonoo H; Tanaka K; Ikeda M; Shiiki S; Yamamoto Y; Nomura T; Sohda M; Seki M; Miyake A; Moriya T; Sadahira Y; Mimura H; Fukunaga M
    Breast Cancer; 2010; 17(1):17-21. PubMed ID: 19466508
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].
    Valdés Olmos RA; Jansen L; Muller SH; Hoefnagel CA; Nieweg O
    Rev Esp Med Nucl; 1999; 18(2):111-21. PubMed ID: 10352326
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sentinel lymph node biopsy in breast cancer New indications and our experience.
    Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V
    Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?
    Magnoni F; Corso G; Gilardi L; Pagan E; Massari G; Girardi A; Ghidinelli F; Bagnardi V; Galimberti V; Grana CM; Veronesi P
    Future Oncol; 2022 Jan; 18(2):193-204. PubMed ID: 34882010
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [SPECT-CT: a new tool for localisation of sentinel lymph nodes in breast cancer patients].
    Mucientes Rasilla J; Farge Balbín L; Cardona Arboniés J; Moreno Elola-Olaso A; Delgado-Bolton R; Izarduy Pereyra L; Rodríguez Rey C; Lapeña Gutiérrez L; González Maté A; Román Santamaría JM; Carreras Delgado JL
    Rev Esp Med Nucl; 2008; 27(3):183-90. PubMed ID: 18570860
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer.
    Roumen RM; Kuijt GP; Liem IH
    Eur J Surg Oncol; 2006 Dec; 32(10):1076-81. PubMed ID: 16996237
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
    Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Sentinel lymph node biopsy in breast cancer].
    Rody A; Solbach C; Kaufmann M
    Chirurg; 2004 Aug; 75(8):767-73. PubMed ID: 15221088
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node.
    Snoj M; Bracko M; Zagar I
    Croat Med J; 2005 Jun; 46(3):377-81. PubMed ID: 15861515
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).
    Boughey JC; Ballman KV; Le-Petross HT; McCall LM; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Feliberti EC; Hunt KK
    Ann Surg; 2016 Apr; 263(4):802-7. PubMed ID: 26649589
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.
    Gatek J; Vrana D; Hnatek L; Bakala J; Dudesek B; Duben J; Musil T
    J BUON; 2012; 17(2):265-70. PubMed ID: 22740204
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
    Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
    J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.